Causes of Premenstrual Dysphoric Disorder (PMDD)
PMDD is caused by an abnormal sensitivity to normal hormonal fluctuations during the menstrual cycle, specifically involving altered brain responses to progesterone metabolites and serotonin dysregulation, rather than abnormal hormone levels themselves. 1, 2
Primary Pathophysiological Mechanisms
Neurosteroid Sensitivity (Core Mechanism)
The fundamental cause involves differential sensitivity of the GABAergic system to allopregnanolone, a neurosteroid metabolite of progesterone produced after ovulation 3, 2, 4. Women with PMDD exhibit:
- Altered GABA-A receptor configuration: Allopregnanolone binds to neurosteroid sites on GABA receptors, changing their structure and rendering them resistant to activation, which decreases central GABA-mediated inhibition 4
- Paradoxical response: While allopregnanolone is sedative at high concentrations in most women, it causes anxiety and irritability at lower levels in PMDD-susceptible individuals 5
- Receptor subunit differences: Brain imaging studies show differences in GABA-A receptor subcomposition in women with PMDD compared to controls 5
Serotonergic Dysfunction
The serotonin system shows deficient functioning in PMDD 2, 4:
- Lowered serotonin produces PMS-like symptoms
- Serotonergic activity in the brain appears deficient by multiple measurement methods
- This explains why SSRIs are effective even when administered only during the luteal phase 4
Critical Distinction About Hormone Levels
Women with PMDD have normal hormone levels—the problem is how their brains respond to these hormones 2, 5. Key evidence:
- No differences in estradiol or progesterone levels are found between PMDD patients and controls 6
- Hormone levels do not correlate with symptom severity 6
- The landmark Bloch study demonstrated that administering and withdrawing hormones triggered symptoms only in women with PMDD history, despite identical hormone levels in both groups 6
Contributing Factors
Genetic and Epigenetic Influences
- Genetic modifications of hormonal and neurotransmitter pathways play a role 3
- Familial aggregation has been demonstrated 6
- Research in this area remains limited but emerging 1
Inflammatory Mechanisms
- Peripheral inflammatory molecules (cytokines, interleukins, C-reactive protein) may interact with brain neurotransmitter systems 3
- Neuroinflammation represents a potential link between peripheral and neurological responses to stressors 3
Psychosocial Stressors
While not primary causes, stress and psychological factors can interact with biological vulnerability 7:
- Stress may modulate symptom severity
- Neurosteroids and stress represent interconnected pathways 7
Clinical Implications
The pathophysiology explains why:
- Ovulation suppression works: Eliminating progesterone production removes the trigger 2, 5
- SSRIs are first-line: They correct serotonergic deficiency 2
- Hormone levels are unhelpful diagnostically: Testing estradiol or progesterone concentrations provides no useful information 6, 4
- Symptoms are luteal-phase specific: They only occur when progesterone (and thus allopregnanolone) is present 4, 5
Common pitfall: Clinicians often search for hormonal abnormalities in PMDD patients. This is futile—the disorder reflects abnormal brain sensitivity to normal hormones, not abnormal hormone production 6, 2.